Perturbed functional networks in Alzheimers Disease reveal opposing roles for TGIF and EGR3
Saranya Canchi, Balaji Raao, Deborah Masliah, Sara Brin RosenthaliD, Roman ŠášikiD, Kathleen M FischiD, Philip L. De JageriD, David A. Bennett, Robert A. RissmaniD
Abstract
While Alzheimers disease (AD) is the most prevalent cause of dementia, complex combinations of the underlying pathologies have led to evolved concepts in clinical and neuropathological criteria in the past decade. Pathological AD can be decomposed into subsets of individuals with significantly different antemortem cognitive decline rates. Using transcriptome as a proxy for functional state, we preselected 414 expression profiles of clinically and neuropathologically confirmed AD subjects and age matched non-demented controls sampled from a large community based neuropathological study. By combining brain tissue specific protein interactome with gene network, we identify functionally distinct composite clusters of genes which reveal extensive changes in expression levels in AD. The average global expression for clusters corresponding to synaptic transmission, metabolism, cell cycle, survival and immune response were downregulated while the upregulated cluster had a large set of uncharacterized pathways and processes that may constitute an AD specific phenotypic signature. We identified four master regulators across all clusters of differentially expressed genes by enrichment analysis including TGIF1 and EGR3. These transcription factors have previously not been associated with AD and were validated in brain tissue samples from an independent AD cohort. We identify TGIF1, a transcriptional repressor as being neuroprotective in AD by activating co-repressors regulating genes critical for DNA repair, maintaining homeostasis and arresting cell cycle. In addition, we show that loss of EGR3 regulation, mediates synaptic deficits by targeting the synaptic vesicle cycle. Collectively, our results highlight the utility of integrating protein interactions with gene perturbations to generate a comprehensive framework for characterizing the alterations in molecular network as applied to AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systems genetic dissection of Alzheimer's disease brain gene expression networks
Pinghan Zhao, Omar El Fadel, … Joshua M Shulman·bioRxiv·Oct 4, 2024
- Transcriptomic profiling of the middle temporal gyrus reveals differential glial/neuronal dysregulation across Alzheimer disease and aging.
Ignazio Stefano Piras, Anna Bonfitto, … Matthew J. Huentelman·bioRxiv·Oct 19, 2025
- Systematic Analysis of Biological Processes Reveals Gene Co-expression Modules Driving Pathway Dysregulation in Alzheimer's Disease
Temitope Adeoye, Syed Islamuddin Shah, Ghanim Ullah·Aging and DiseasePeer-reviewed·Jan 1, 2024
- Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease
Samuel Morabito, Emily Miyoshi, … Vivek Swarup·Human Molecular GeneticsPeer-reviewed·Aug 12, 2020
- Transcriptional dysregulation study reveals a core network involving the genesis for Alzheimer’s disease
Guofeng Meng, Hongkang Mei·bioRxiv·Dec 26, 2017
- Transcriptomic signatures of Abeta- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer's disease pathophysiology
Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, … Yasser Iturria‐Medina·bioRxiv·Sep 15, 2023